177 related articles for article (PubMed ID: 23325305)
1. Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure.
Andrade C; Kumar CB; Surya S
Int Clin Psychopharmacol; 2013 May; 28(3):145-55. PubMed ID: 23325305
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin.
Serebruany VL; Glassman AH; Malinin AI; Atar D; Sane DC; Oshrine BR; Ferguson JJ; O'Connor CM
Eur J Heart Fail; 2003 Aug; 5(4):517-21. PubMed ID: 12921813
[TBL] [Abstract][Full Text] [Related]
3. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
Andrade C; Sandarsh S; Chethan KB; Nagesh KS
J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
[TBL] [Abstract][Full Text] [Related]
4. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.
Wozniak G; Toska A; Saridi M; Mouzas O
Med Sci Monit; 2011 Sep; 17(9):RA205-14. PubMed ID: 21873959
[TBL] [Abstract][Full Text] [Related]
5. Treating depression in coronary artery disease and chronic heart failure: what's new in using selective serotonin re-uptake inhibitors?
Paraskevaidis I; Palios J; Parissis J; Filippatos G; Anastasiou-Nana M
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):109-15. PubMed ID: 22471956
[TBL] [Abstract][Full Text] [Related]
6. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?
Schlienger RG; Meier CR
Am J Cardiovasc Drugs; 2003; 3(3):149-62. PubMed ID: 14727927
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.
Thomas KL; Ellingrod VL; Bishop JR; Keiser MJ
Psychopharmacol Bull; 2010; 43(1):11-22. PubMed ID: 20581797
[TBL] [Abstract][Full Text] [Related]
8. Crucial interactions between selective serotonin uptake inhibitors and sigma-1 receptor in heart failure.
Bhuiyan MS; Tagashira H; Fukunaga K
J Pharmacol Sci; 2013; 121(3):177-84. PubMed ID: 23428811
[TBL] [Abstract][Full Text] [Related]
9. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.
van Melle JP; de Jonge P; van den Berg MP; Pot HJ; van Veldhuisen DJ
Drugs; 2006; 66(16):2095-107. PubMed ID: 17112303
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.
de Abajo FJ
Drugs Aging; 2011 May; 28(5):345-67. PubMed ID: 21542658
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.
Ramasubbu R
J Clin Psychiatry; 2004 Dec; 65(12):1642-53. PubMed ID: 15641869
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of antidepressant drugs: updated.
Glassman AH
J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
[TBL] [Abstract][Full Text] [Related]
13. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
[TBL] [Abstract][Full Text] [Related]
14. The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Leftheriotis D; Flevari P; Ikonomidis I; Douzenis A; Liapis C; Paraskevaidis I; Iliodromitis E; Lykouras L; Kremastinos DT
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1217-23. PubMed ID: 20487349
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.
Mourilhe P; Stokes PE
Drug Saf; 1998 Jan; 18(1):57-82. PubMed ID: 9466088
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
Bermel RA; Hashmonay R; Meng X; Randhawa S; von Rosenstiel P; Sfikas N; Kantor D
Mult Scler Relat Disord; 2015 May; 4(3):273-80. PubMed ID: 26008945
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment of depression in patients with heart disease.
Roose SP; Miyazaki M
Psychosom Med; 2005; 67 Suppl 1():S54-7. PubMed ID: 15953802
[TBL] [Abstract][Full Text] [Related]
19. Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure.
Henze M; Tiniakov R; Samarel A; Holmes E; Scrogin K
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H444-54. PubMed ID: 23220332
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
